Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Rimeporide

EU orphan designation number: EU/3/15/1478   
Active ingredient: Rimeporide
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: EUDRAC Limited
Hampden House, Monument Business Park, Chalgrove, OX44 7RW United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/04/2015 Orphan designation EMA/OD/307/14 (2015)2942 of 24/04/2015